|
⚲
|
| Keyboard |
| Esperion Therapeutics Inc | |
|---|---|
| Ticker | ESPR |
| CIK # | 0001434868 |
| CUSIP | 29664W105 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 46701 Commerce Center Drive, Plymouth, MI 48170 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Esperion Therapeutics Inc | 2014-07-15 | Exemption: 506(b) · Remaining: Indefinite · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001434868] | 10-K | |
| [0001434868] | 10-Q | |
| [0001434868] | 3 | |
| [0001434868] | 4 | |
| [0001434868] | 5 | |
| [0001434868] | 8-K | |
| [0001434868] | D | |
| [0001434868] | SC 13D | |
| [0001434868] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Looker Benjamin
Common Stock
|
2026-03-17 | Sell | 5,708 | $2.70 | 15,412 |
|
Halladay Benjamin
Common Stock
|
2026-03-17 | Sell | 6,424 | $2.71 | 17,409 |
|
Koenig Sheldon L
Common Stock
|
2026-03-17 | Sell | 25,578 | $2.72 | 69,572 |
|
Halladay Benjamin
Stock Option (right to buy) · derivative
|
2026-03-13 | Grant | 221,270 | $0.00 | |
|
Looker Benjamin
Stock Option (right to buy) · derivative
|
2026-03-13 | Grant | 269,230 | $0.00 | |
|
Koenig Sheldon L
Common Stock
|
2026-03-13 | Grant | 723,760 | $0.00 | |
|
Koenig Sheldon L
Stock Option (right to buy) · derivative
|
2026-03-13 | Grant | 647,460 | $0.00 | |
|
Halladay Benjamin
Common Stock
|
2026-03-13 | Grant | 247,430 | $0.00 | |
|
Looker Benjamin
Common Stock
|
2026-03-13 | Grant | 300,840 | $0.00 | |
|
Looker Benjamin
Common Stock
|
2026-01-20 | Sell | 1,689 | $2.88 | 4,864 |
|
Halladay Benjamin
Common Stock
|
2025-12-17 | Sell | 7,337 | $3.67 | 26,927 |
|
Koenig Sheldon L
Common Stock
|
2025-12-17 | Sell | 48,244 | $3.67 | 177,055 |
|
Looker Benjamin
Common Stock
|
2025-12-17 | Sell | 6,517 | $3.67 | 23,917 |
|
Harlow John B Jr
Common Stock
|
2025-12-04 | Grant | 424,536 | $0.00 | |
|
Harlow John B Jr
Stock Option (right to buy) · derivative
|
2025-12-04 | Grant | 380,000 | $0.00 | |
|
Looker Benjamin
Common Stock
|
2025-10-17 | Sell | 1,248 | $2.62 | 3,270 |
|
Common Stock
|
2025-09-17 | Sell | 6,267 | $2.80 | 17,548 |
|
Common Stock
|
2025-09-17 | Sell | 28,427 | $2.79 | 79,311 |
|
Common Stock
|
2025-09-17 | Sell | 7,046 | $2.81 | 19,799 |
|
Halladay Benjamin
Common Stock
|
2025-07-17 | Sell | 11 | $1.12 | 12 |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 207 | 177,897,759 |
| 2025-12-31 | 202 | 156,162,923 |
| 2025-09-30 | 191 | 109,928,496 |
| 2025-06-30 | 162 | 99,495,578 |
| 2025-03-31 | 188 | 113,357,292 |
| 2024-12-31 | 194 | 128,910,605 |
| 2024-09-30 | 189 | 134,036,645 |
| 2024-06-30 | 183 | 142,982,929 |
| 2024-03-31 | 158 | 133,450,884 |
| 2023-12-31 | 136 | 77,914,930 |
| 2023-09-30 | 128 | 78,913,687 |
| 2023-06-30 | 129 | 75,828,564 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Trium Capital LLP | [2026-06-30] | SOLE | 11,158,150 | 11,158,150 |
| Wasatch Advisors LP | [2026-06-30] | SOLE | 1,930,185 | 1,930,185 |
| Equitec Proprietary Markets LLC | [2026-06-30] | SOLE | 345,800 | 823,700 |
| Eleva Capital SAS | [2026-06-30] | SOLE | 0 | 183,047 |
| ABC Arbitrage Sa | [2026-06-30] | OTR | 0 | 42,553 |
| CFS Investment Advisory Services LLC | [2026-06-30] | SOLE | 0 | 24,551 |
| Spire Wealth Management | [2026-06-30] | SOLE | 0 | 17,767 |
| Wealth Enhancement Advisory Services LLC | [2026-06-30] | SOLE | 0 | 12,321 |
| Affinity Capital Advisors LLC | [2026-06-30] | SOLE | 0 | 10,000 |
| MassMutual Private Wealth & Trust FSB | [2026-06-30] | SOLE | 2,050 | 2,050 |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 243 | 243 |
| City State Bank | [2026-06-30] | SOLE | 200 | 200 |
| Gamma Investing LLC | [2026-06-30] | DFND | 141 | 141 |
| FNY Investment Advisers LLC | [2026-06-30] | SOLE | 110,000 | 109 |
| IFP Advisors LLC | [2026-06-30] | SOLE | 3 | 3 | Prev | Page 1 | Next |